Real-World (RW) treatment patterns in patients with T2DM newly initiated with antihyperglycemic (AHA) medications in the US

被引：0
|
作者：
Cai, Jennifer [1 ]
Burudpakdee, Chakkarin [2 ]
Divino, Victoria [2 ]
Fegade, Mayuresh [3 ]
机构：
[1] Janssen, Beerse, Belgium
[2] IMS Hlth, Danbury, CT USA
[3] Janssen Med Affairs, Bombay, Maharashtra, India
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2016年 / 120卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PD-82
引用
收藏
页码：S117 / S117
页数：1
相关论文
共 50 条
  • [41] A Real-World Study of Disease-Modifying Drug Treatment Patterns in US Patients with Multiple Sclerosis Newly Initiating Treatment
    Nicholas, Jacqueline
    Edwards, Natalie C.
    Harlow, Danielle
    Phillips, Amy
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 20 - 20
  • [42] INTENSIFY: effectiveness of insulin degludec/liraglutide (IDegLira) in a real-world T2DM population in the UAE
    Al Awadi, F.
    Aly, H.
    Bashier, A.
    Benavente, J. Medina
    Dhanwal, D. Kumar
    Jallo, M.
    Singhal, S.
    Abusnana, S.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [43] Real-world (RW) characteristics, treatment patterns, and outcomes of patients with cholangiocarcinoma (CCA) treated with pemigatinib
    Saverno, Kim
    Brown-Bickerstaff, Cherrishe
    Kotomale, Angele
    Rodriguez, Michael A.
    Feinberg, Bruce A.
    Gordon, Sarah
    Ren, Haobo
    Braunstein, Evan Mark
    Kim, Richard D.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 444 - 444
  • [44] REAL-WORLD ADHERENCE AND PERSISTENCE AMONG ELDERLY PATIENTS WITH T2DM INITIATING DULAGLUTIDE VS. LIRAGLUTIDE OR EXENATIDE ONCE-EEKLY IN THE US
    Yu, M.
    Xu, Y.
    Kwan, A.
    Bunniran, S.
    Mody, R.
    Meah, Y.
    Changamire, T.
    Nair, R.
    VALUE IN HEALTH, 2019, 22 : S159 - S159
  • [45] Obese T2DM Patients Gain Less Weight with Insulin Treatment Compared with Normal and Overweight Patients: New Evidence from Real-World Data
    Paul, Sanjoy
    Shaw, Jonathan
    Klein, Kerenaftali
    DIABETES, 2016, 65 : A236 - A236
  • [46] Evolving Real-World Treatment Patterns in Patients with Newly-Diagnosed Multiple Myeloma (NDMM) in the United States (US)
    Ailawadhi, Sikander
    Romanus, Dorothy
    Cherepanov, Dasha
    Yin, Yu
    Cheng, Meng-Ru
    Hari, Parameswaran
    BLOOD, 2019, 134
  • [47] REAL-WORLD TREATMENT PATTERNS AND TIME TO DISCONTINUATION IN RHEUMATOID ARTHRITIS PATIENTS IN THE US
    Radtchenko, J.
    Smith, Y.
    Feinberg, B.
    VALUE IN HEALTH, 2017, 20 (09) : A540 - A540
  • [48] Nonalcoholic Fatty Liver Disease (NAFLD) in Type 2 Diabetes Mellitus (T2DM) Patients in India: A Real-World Perspective
    Singh, Vikram Jit
    Singh, Manmohan
    Patidar, Hemant
    DIABETES, 2020, 69
  • [49] Therapeutically Exchangeable? A Real-World Outcome Study of Switching between Basal Insulin Analogs among T2DM Patients
    Levin, Philip
    Wei, Wenhui
    Miao, Raymond
    Xie, Lin
    Ye, Fen
    Baser, Onur
    Gill, Jasvinder K.
    DIABETES, 2014, 63 : A234 - A234
  • [50] Real-world treatment patterns of adults with psoriasis initiated on apremilast or biologics
    Wu, Jashin J.
    Wang, Ann
    Jobson, Greeta
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB101 - AB101
12345